Ser Educacional (SEER3) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
26 Nov, 2025Executive summary
Achieved highest adjusted EBITDA of R$143.7 million (26.6% margin) and net operating cash generation post-CAPEX of R$75.5 million since IPO, with net income reaching R$43.6 million and adjusted net income at R$51.8 million.
Net revenue grew 19.8% year-over-year to R$540.0 million, driven by a 15.2% increase in hybrid undergraduate students and expansion in medical course enrollments.
Four consecutive years of organic growth in hybrid learning undergraduate enrollment, with total undergraduate student base up 10.3% to 346,300.
Operational leverage and cost control led to significant margin improvements and profit conversion.
Net debt/adjusted EBITDA improved to 1.35x, marking the ninth consecutive quarterly reduction.
Financial highlights
Consolidated net revenues rose 19.8% year-over-year to R$540.0 million in 1Q25, with organic growth in the student base, especially in medical and hybrid courses.
Adjusted EBITDA increased 57.9% year-over-year to R$143.7 million, with margin up to 26.6%, the highest since IPO.
Net income improved to R$43.6 million from a loss of R$17.5 million in 1Q24; adjusted net income was R$51.8 million.
Net operating cash generation post-CAPEX grew 81.8% year-over-year to R$75.5 million.
CapEx totaled R$22.7 million, mainly for campus renovations and equipment, representing 4.1% of net revenues.
Outlook and guidance
Focus on organic growth, especially in hybrid education and health courses, with continued investment in new courses and infrastructure.
Management aims to maximize educational assets, process automation, and financial discipline for expansion.
Ongoing efforts to expand medical course places, awaiting further regulatory approvals.
Latest events from Ser Educacional
- Adjusted net income rose 8.5% to R$46.2M, with strong hybrid and health course growth.SEER3
Q2 20242 Feb 2026 - Revenue and EBITDA surged as leverage fell, led by health and medicine course expansion.SEER3
Q3 202414 Jan 2026 - Strong earnings, cash generation, and medical course expansion drive margin and debt improvement.SEER3
Q4 202427 Dec 2025 - Net income up 66.4%, hybrid enrollment up 13.8%, and net debt/EBITDA down to 1.24x.SEER3
Q2 202523 Nov 2025 - Adjusted net income up 24.5% and net debt down 21.9% on Hybrid Learning and margin gains.SEER3
Q3 202517 Nov 2025 - Hybrid learning growth and operational gains drove profitability and lower net debt in Q1 2024.SEER3
Q1 20243 Jun 2025